2010Zhonghua laonian xin-nao-xueguanbing zazhiRequires access

Effect of spironolactone and valsartan on apoptosis-associated protein in cadiomyocytes of hypertensive rats

Xiaofeng Long

Open publisher page 0 citations

Abstract

Objective To investigate the effect of spironolactone and valsartan on expression of apoptosis -associated protein P53,Bax and Bcl-2 in left ventricular myocytes of renovascular hypertension rats.Methods Forty-six male SD rats were randomized to hypertension group(group N, n = 12),spironolactone group(group S,n = 12) ,valsartan group(group Ⅴ,n = 11) ,spironolactone and valsartan group(group S+V,n = 11) ,control group(group C,n = 10).After 10 weeks of treatment,echocardiography was performed and carotid artery blood pressure was measured. Immunohistochemistry was adopted to examine the protein expression of P53,Bax and Bcl-2.Results Affer treatment for 10 weeks,compared with group Cthe blood pressure was higher in group N (P 0.01).Compared with group N,the blood pressure of groups Ⅴ and S+V was significantly decreased (P 0.05).Compared with group CBax,Bcl-2 and Bax/Bcl-2 were significantly increased in group N,Bax and Bax/Bcl-2 in group S were significantly increased (P 0.05,P 0.01).Compared with group N,Bax,Bax/Bcl-2 in group S and Bax,Bcl-2 ,Bax/Bcl-2 in groups V and S+V were significantly decreased.Compared with group S,Bax and Bax/Bcl-2 in groups V and S+V were significantly decreased (P 0.05,P 0.01).Conclusions Treatment with valsartan and spironolactone can decrease the expression of P53 and Bax in myocardium,inhibit the occurrence and partly reverse the LVH of renovascular hypertension rats.

About this research paper

What this paper is about

Objective To investigate the effect of spironolactone and valsartan on expression of apoptosis -associated protein P53,Bax and Bcl-2 in left ventricular myocytes of renovascular hypertension rats.Methods Forty-six male SD rats were randomized to hypertension group(group N, n = 12),spironolactone group(group S,n = 12) ,valsartan group(group Ⅴ,n = 11) ,spironolactone and valsartan group(group S+V,n = 11) ,control group(group C,n = 10).After 10 weeks of treatment,echocardiography was performed and carotid artery blood pressure was measured. Immunohistochemistry was adopted to examine the protein expression of P53,Bax and Bcl-2.Results Affer treatment for 10 weeks,compared with group Cthe blood pressure was higher in group N (P 0.01).Compared with group N,the blood pressure of groups Ⅴ and S+V was significantly decreased (P 0.05).Compared with group CBax,Bcl-2 and Bax/Bcl-2 were significantly increased in group N,Bax and Bax/Bcl-2 in group S were significantly increased (P 0.05,P 0.01).Compared with group N,Bax,Bax/Bcl-2 in group S and Bax,Bcl-2 ,Bax/Bcl-2 in groups V and S+V were significantly decreased.Compared with group S,Bax and Bax/Bcl-2 in groups V and S+V were significantly decreased (P 0.05,P 0.01).Conclusions Treatment with valsartan and spironolactone can decrease the expression of P53 and Bax in myocardium,inhibit the occurrence and partly reverse the LVH of renovascular hypertension rats.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of spironolactone and valsartan on expression of apoptosis -associated protein P53,Bax and Bcl-2 in left ventricular myocytes of renovascular hypertension rats.Methods Forty-six male SD rats were randomized to hypertension group(group N, n = 12),spironolactone group(group S,n = 12) ,valsartan group(group Ⅴ,n = 11) ,spironolactone and valsartan group(group S+V,n = 11) ,control group(group C,n = 10).After 10 weeks of treatment,echocardiography was performed and carotid artery blood pressure was measured. Immunohistochemistry was adopted to examine the protein expression of P53,Bax and Bcl-2.Results Affer treatment for 10 weeks,compared with group Cthe blood pressure was higher in group N (P 0.01).Compared with group N,the blood pressure of groups Ⅴ and S+V was significantly decreased (P 0.05).Compared with group CBax,Bcl-2 and Bax/Bcl-2 were significantly increased in group N,Bax and Bax/Bcl-2 in group S were significantly increased (P 0.05,P 0.01).Compared with group N,Bax,Bax/Bcl-2 in group S and Bax,Bcl-2 ,Bax/Bcl-2 in groups V and S+V were significantly decreased.Compared with group S,Bax and Bax/Bcl-2 in groups V and S+V were significantly decreased (P 0.05,P 0.01).Conclusions Treatment with valsartan and spironolactone can decrease the expression of P53 and Bax in myocardium,inhibit the occurrence and partly reverse the LVH of renovascular hypertension rats.

Key concepts: Valsartan, Spironolactone, Medicine, Apoptosis, Blood pressure, Internal medicine, BAX Protein, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of spironolactone and valsartan on apoptosis-associated protein in cadiomyocytes of hypertensive rats — Research Paper | ScholarLens